Microbial mutagenicity and in vitro chromosome aberration induction by FK973, a new antitumor agent
- 30 June 1994
- journal article
- research article
- Published by Elsevier BV in Mutation Research Letters
- Vol. 324 (1-2), 43-50
- https://doi.org/10.1016/0165-7992(94)90066-3
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Comparison of Salmonella typhimurium TA102 with Escherichia coli WP2 tester strainsMutagenesis, 1990
- Specific Metabolic Activation of FK973, a New Antitumor Antibiotic, in L1210 Leukemia CellsThe Japanese Journal of Pharmacology, 1990
- One-electron reduction of mitomycin c by rat liver: Role of cytochrome P-450 and NADPH-cytochrome P-450 reductaseXenobiotica, 1990
- A new antitumor antibiotic, FK973: Its metabolism in the blood and the antitumor effects of its metabolites on experimental models.The Japanese Journal of Pharmacology, 1989
- Structure of FR 900482, a novel antitumor antibiotic from a StreptomycesJournal of the American Chemical Society, 1987
- Reductive metabolism and alkylating activity of mitomycin C induced by rat liver microsomesBiochemistry, 1981
- The development of a “microtitreR” fluctuation test for the detection of indirect mutagens, and its use in the evaluation of mixed enzyme induction of the liverMutation Research, 1979
- Mutagenicities of N-nitrosamines on salmonellaMutation Research, 1977
- Mutation by mitomycins in the ultraviolet light-sensitive mutant of Escherichia coliMutation Research, 1973
- Mitomycins and Porfiromycin: Chemical Mechanism of Activation and Cross-linking of DNAScience, 1964